Faculty
Sheila Arquette, RPH
President & CEO
National Association of Specialty Pharmacy
 
Russell G. Buhr, MD, PhD, FACP, ATSF
Assistant Professor of Medicine & Health Policy and Management
Staff Pulmonologist
Greater Los Angeles Veterans Affairs Healthcare System
Core Investigator
VA HSR Center for the Study of Healthcare Innovation, Implementation, & Policy (CSHIIP)
UCLA Health
 
Robert O. Cotes, MD, DFAPA
Associate Professor and Distinguished Physician
Director, Clinical & Research Program for Psychosis at Grady Health System
Director, Project ARROW at Grady Health System
Physician Expert, SMI Adviser
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
 
Alta DeRoo, MD, MBA
Distinguished fellow, American Society of Addiction Medicine
Chief Medical Officer
Hazelden Betty Ford Foundation
 
Kelly Grosklags, LICSW, BCD, FAAGC, FT
Conversations with Kelly
 
Jeffrey Kahn, PhD, MPH
Professor, Department of Health Policy and Management,
Johns Hopkins Bloomberg School of Public Health;
Andreas C Dracopoulos Director,
Robert Henry Levi and Ryda Hecht Levi Professor of Bioethics and Public Policy,
Johns Hopkins Berman Institute of Bioethics
 
Trishan Panch, MD, MPH
Co-Founder, Wellframe
President
Harvard T.H. Chan School of Public Health Alumni Association
Instructor
Harvard T.H. Chan School of Public Health
 
Jeffrey Teuteberg, MD
Section Chief of Heart Failure, Cardiac Transplant and Mechanical Circulatory Support
Professor of Medicine
Division of Cardiology
Stanford Medicine
 
Planners
Elizabeth Albert, MD
Clinical Activity Manager
Optum Health Education
Eden Prairie, MN

Neil Braunstein, MD
Senior Medical Director Specialty
Optum Health, Clinical Performance

Sara Fleszar, PharmD, BCOP
Senior Clinical Pharmacist
Optum Health Solutions

Rebecca Gleason, RN, CCM
Activity Manager
Optum Health Education
Eden Prairie, MN

Lisa Latts, MD, MSPH, MBA, FACP
Senior Medical Director, Value-Based Care
Optum
Eden Prairie, MN

Jennifer Malin, MD, PhD
Senior Vice President and Chief Medical Officer
Optum Health Solutions
Eden Prairie, MN

Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, OptumHealth Education (OHE) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. OHE ensures that the content is independent of commercial bias.

The list below includes individuals that have relevant financial relationships. 
Financial Relationship Key A-Advisory Board CT-Clinical Trial C-Consultant E-Employee G- Grant/Research Support or Funding I-Stocks and Other Ownership Interests S-Speakers’ Bureau O-Other Financial or Material Support

• Sheila Arquette, RPH: Prime Meridian Group (A); Wellsky (S)
• Russell Buhr, MD, PhD, FACP, ATSF: Chiesi (A, C)
• Robert Cotes, MD, DFAPA: Karuna (G)
• Trishan Panch, MD, MPH: HealthEdge, Lumin (I)
• Jeffrey Teuteberg, MD: CareDx, Medtronic (A, S); Paragonix (S); Takeda (A) 

All relevant financial relationships have been mitigated. 

The remaining activity faculty or planners have no financial relationships to disclose.